Article Details
Retrieved on: 2021-03-18 10:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
SOUTH SAN FRANCISCO, Calif., March 18, 2021 /PRNewswire/ -- Sutro Biopharma, Inc.. (NASDAQ: STRO), a clinical-stage drug discovery, ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here